Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
RN7SKP117 encodes a pseudogene related to the RN7SK small nuclear RNA, which is a component of the 7SK snRNP complex involved in the regulation of transcription elongation by RNA polymerase II[3][5]. Unlike the functional RN7SK gene—which is a regulatory long noncoding RNA that modulates gene transcription, cell cycle, and is related to pathways like cell differentiation and immune response[1][2][4]—RN7SKP117 itself is classified as a pseudogene and does not encode a functional molecule, nor does it participate directly in biological processes or act as a therapeutic target. Pseudogenes are generally nonfunctional remnants of genes and do not serve as receptors, enzymes, transporters, transcription factors, or regulators. No specific disease associations or drug interactions are known for this pseudogene.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on RN7SK pseudogene 117 (RN7SKP117).